Xenium Cell Segmentation Equipment and Supplies

The National Heart, Lung, and Blood Institute (NHLBI), a component of the Department of Health and Human Services, is seeking to procure Xenium Cell Segmentation Equipment and Supplies through this solicitation. The procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS category (334516) and is classified under the Laboratory Equipment and Supplies PSC category (6640). This solicitation is a standard competitive procurement with no specific set-aside designations, indicating that all qualified vendors may compete for the contract. The solicitation was posted on December 2, 2024, with proposals due by December 16, 2024, providing potential vendors approximately two weeks to prepare and submit their responses. While specific evaluation criteria are not explicitly detailed in the notice, typical federal procurement standards would likely include factors such as technical capability, pricing, vendor experience, and compliance with specifications.

The contract appears focused on acquiring specialized scientific equipment for cell segmentation research, likely supporting advanced biomedical research initiatives at the National Institutes of Health. As a civilian agency procurement, the contract will presumably be performed at NHLBI research facilities, potentially in the Maryland or Washington, D.C. metropolitan area. The solicitation does not specify precise quantity requirements or potential award values, which suggests vendors should be prepared to provide comprehensive pricing and capability details in their proposals. The procurement is not limited to small businesses or specific socio-economic categories, thereby allowing broad participation from potential suppliers of advanced laboratory instrumentation. Given the technical nature of cell segmentation equipment, prospective vendors will likely need to demonstrate sophisticated scientific and manufacturing capabilities to be competitive in this solicitation.